Cite

HARVARD Citation

    Lutz, M. et al. (2014). Improvement of quality of life in patients with steroid‐refractory chronic graft‐versus‐host disease treated with the mTOR inhibitor everolimus. Clinical transplantation. pp. 1410-1415. [Online]. 
  
Back to record